S.A. Mason’s Acutus Medical Inc AFIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,000
| Closed | -$4 | – | 369 |
|
|
2025
Q2 | $4 | Hold |
2,000
| – | – | ﹤0.01% | 362 |
|
|
2025
Q1 | $85 | Sell |
2,000
-1,000
| -33% | -$43 | ﹤0.01% | 348 |
|
|
2024
Q4 | $165 | Hold |
3,000
| – | – | ﹤0.01% | 342 |
|
|
2024
Q3 | $252 | Sell |
3,000
-3,400
| -53% | -$286 | ﹤0.01% | 324 |
|
|
2024
Q2 | $227 | Hold |
6,400
| – | – | ﹤0.01% | 318 |
|
|
2024
Q1 | $1.2K | Hold |
6,400
| – | – | ﹤0.01% | 311 |
|
|
2023
Q4 | $1.29K | Hold |
6,400
| – | – | ﹤0.01% | 312 |
|
|
2023
Q3 | $4.46K | Hold |
6,400
| – | – | ﹤0.01% | 304 |
|
|
2023
Q2 | $4.83K | Hold |
6,400
| – | – | ﹤0.01% | 306 |
|
|
2023
Q1 | $4.83K | Hold |
6,400
| – | – | ﹤0.01% | 306 |
|
|
2022
Q4 | $7.36K | Sell |
6,400
-1,700
| -21% | -$1.4K | 0.01% | 296 |
|
|
2022
Q3 | $7K | Hold |
8,100
| – | – | 0.01% | 307 |
|
|
2022
Q2 | $9K | Hold |
8,100
| – | – | 0.01% | 309 |
|
|
2022
Q1 | $11K | Hold |
8,100
| – | – | 0.01% | 312 |
|
|
2021
Q4 | $28K | Sell |
8,100
-6,200
| -43% | -$34.9K | 0.02% | 284 |
|
|
2021
Q3 | $126K | Buy |
+14,300
| New | +$188K | 0.08% | 182 |
|
S.A. Mason's AFIB Position: Q3 2025 in Review
S.A. Mason sold out of Acutus Medical Inc (AFIB) in Q3 2025, closing a stake of 2,000 shares — an estimated $4 sold.
S.A. Mason first reported a position in AFIB in Q3 2021 and held it in 16 quarters. The position peaked at $126K in Q3 2021. 0 funds tracked by Wall St. Rank hold AFIB as of Q3 2025.
- S.A. Mason reported no remaining Acutus Medical Inc position as of Q3 2025 after selling out during the quarter.
- S.A. Mason sold 2,000 Acutus Medical Inc shares in Q3 2025, an estimated $4.
- S.A. Mason first reported a position in Acutus Medical Inc in Q3 2021 and held it in 16 quarters.
- S.A. Mason's Acutus Medical Inc position peaked at $126K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2025.
Based on S.A. Mason's 13F filing for Q3 2025, filed 14 Oct 2025.